Pilot study explores early induction for gestational diabetes

NCT ID NCT06641141

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study is testing whether it's practical to run a larger trial that compares inducing labor at 38 weeks versus waiting for natural labor in people with gestational diabetes. About 260 participants will be randomly assigned to either early induction or expectant management. The main goal is to see if enough people can be recruited and if the study procedures work well, not to determine if one approach is safer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Induction of labour (a procedure to start labor using medications or techniques)
What this could lead to
If successful, this pilot could pave the way for a larger trial that may show whether inducing labor at 38 weeks improves outcomes for mothers with gestational diabetes.
What could go wrong
This is a small pilot study focused on feasibility, not on proving safety or effectiveness. Results may not apply to all patients, and the larger trial may still fail to show benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS (GDM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Ottawa Hospital

    RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.